Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland

Article Article scientifique Article Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland eng 2021 author Chen Chaoran author Nadeau Sarah Ann author Topolsky Ivan 512825 author Manceau Marc author Huisman Jana S author Jablonski Kim Philipp author Fuhrmann Lara author Dreifuss David 801087 author Jahn Katharina author Beckmann Christiane author Redondo Maurice author Noppen Christoph author Risch Lorenz author Risch Martin author Wohlwend Nadia author Kas Sinem author Bodmer Thomas author Roloff Tim author Stange Madlen author Egli Adrian author Eckerle Isabella Anne 894639 author Kaiser Laurent 28229 author Denes Rebecca author Feldkamp Mirjam author Nissen Ina author Santacroce Natascha author Burcklen Elodie author Aquino Catharine author de Gouvea Andreia Cabral author Moccia Maria Domenica author Grüter Simon author Sykes Timothy author Opitz Lennart author White Griffin author Neff Laura author Popovic Doris author Patrignani Andrea author Tracy Jay author Schlapbach Ralph author Dermitzakis Emmanouil 542683 author Harshmann Keith Duncan 912078 author Xenarios Ioannis 767135 author Pegeot Henri author Cerutti Lorenzo 648408 author Penet Deborah Danièle 541248 author Blin Anthony 935572 author Elies Melyssa author Althaus Christian L author Beisel Christian author Beerenwinkel Niko author Ackermann Martin author Stadler Tanja 100480 10.1016/j.epidem.2021.100480 34488035 1755-4365 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452947/ In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant of Concern (VoC) which is now named B.1.1.7. Based on initial data from the UK and later data from other countries, this variant was estimated to have a transmission fitness advantage of around 40-80 % (Volz et al., 2021; Leung et al., 2021; Davies et al., 2021). B.1.1.7 COVID-19 Pandemic SARS-CoV-2 Transmission advantage Dewey 540 Dewey 616 European Commission 101003688 EU H2020 Swiss National Science Foundation Real-time monitoring of COVID-19 transmission through phylodynamics 31CA30_196267 CH Programmes Swiss National Science Foundation Large-scale testing and tracking of SARS-CoV-2 infection and evolution by deep sequencing 31CA30_196348 CH Programmes 39 Département de biochimie 144 54 Département de microbiologie et médecine moléculaire 21B 56 Département de médecine 221 false 1255 Virus émergents 993 400 Virologie clinique 668 Epidemics 37 2aaacebd-7346-4fcc-b149-efda5373723c Article (Published version) Public 1-s2.0-S1755436521000335-main(2)(1).pdf 3499770 application/pdf CC BY-NC-ND openAccess Faculté des sciences / Section de chimie et biochimie / Département de biochimie Faculté de médecine / Section de médecine fondamentale / Département de microbiologie et médecine moléculaire Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland	Epidemics			2021	370	113

Archive ouverte UNIGE

Harshmann, Keith Duncan